New study aims to sharpen tools for measuring muscle decline in common adult muscular dystrophy
NCT ID NCT07362316
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 30 adults with myotonic dystrophy type 1 (Steinert disease) and 30 healthy volunteers over three years to see how muscle strength and function change naturally over time. Researchers measured things like muscle power, walking ability, and nerve responses to find the most reliable tests for future treatment trials. The goal was not to treat the disease, but to identify the best ways to track progression in future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEINERT MYOTONIC DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre de recherche du CHU de Québec-Université Laval
Laval, Canada
-
Institut de Myologie
Paris, Île-de-France Region, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.